DK3572515T3 - Glykoproteinhormon langtidsvirkende superagonister - Google Patents

Glykoproteinhormon langtidsvirkende superagonister Download PDF

Info

Publication number
DK3572515T3
DK3572515T3 DK19170014.5T DK19170014T DK3572515T3 DK 3572515 T3 DK3572515 T3 DK 3572515T3 DK 19170014 T DK19170014 T DK 19170014T DK 3572515 T3 DK3572515 T3 DK 3572515T3
Authority
DK
Denmark
Prior art keywords
superagonists
glycoprotein hormone
term effective
long
hormone long
Prior art date
Application number
DK19170014.5T
Other languages
English (en)
Inventor
Mariusz Szkudlinski
Bruce D Weintraub
Original Assignee
Trophogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophogen Inc filed Critical Trophogen Inc
Application granted granted Critical
Publication of DK3572515T3 publication Critical patent/DK3572515T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK19170014.5T 2012-07-30 2013-07-29 Glykoproteinhormon langtidsvirkende superagonister DK3572515T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261677331P 2012-07-30 2012-07-30
EP13826476.7A EP2880164B1 (en) 2012-07-30 2013-07-29 Glycoprotein hormone long-acting superagonists

Publications (1)

Publication Number Publication Date
DK3572515T3 true DK3572515T3 (da) 2021-10-11

Family

ID=49995487

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13826476.7T DK2880164T3 (da) 2012-07-30 2013-07-29 Glykoproteinhormon langstidsvirkende superagonister
DK19170014.5T DK3572515T3 (da) 2012-07-30 2013-07-29 Glykoproteinhormon langtidsvirkende superagonister

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK13826476.7T DK2880164T3 (da) 2012-07-30 2013-07-29 Glykoproteinhormon langstidsvirkende superagonister

Country Status (21)

Country Link
US (5) US9187545B2 (da)
EP (4) EP3572515B1 (da)
JP (1) JP6429774B2 (da)
CN (3) CN112458096A (da)
AR (1) AR091936A1 (da)
AU (2) AU2013296709B2 (da)
BR (1) BR112015001885B1 (da)
CA (2) CA3108181A1 (da)
DK (2) DK2880164T3 (da)
ES (2) ES2894135T3 (da)
HR (1) HRP20190847T1 (da)
HU (1) HUE044016T2 (da)
MX (1) MX360717B (da)
NZ (1) NZ707016A (da)
PL (2) PL2880164T3 (da)
PT (2) PT2880164T (da)
RS (1) RS58881B1 (da)
RU (2) RU2668174C2 (da)
UA (1) UA118653C2 (da)
WO (1) WO2014022283A2 (da)
ZA (1) ZA201502778B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10457713B2 (en) 2012-07-30 2019-10-29 Trophogen, Inc. Glycoprotein hormone long-acting superagonists
AU2013296709B2 (en) 2012-07-30 2018-03-08 Trophogen Inc. Glycoprotein hormone long-acting superagonists
CA2929561A1 (en) 2013-11-05 2015-05-14 Trophogen Inc. Glycoprotein hormone long-acting superagonists
BR102015032660B1 (pt) 2015-12-28 2019-05-28 Ouro Fino Saúde Animal Participações S.A. PROCESSO DE PRODUÇÃO DE UMA GONADOTROFINA CORIÔNICA EQUINA RECOMBINANTE (reCG): COMPOSIÇÃO VETERINÁRIA E USO

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
EP0161063B1 (en) 1984-04-03 1991-07-24 Serono Laboratories, Inc. Method of inducing ovulation
US5008050A (en) 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
EP0290644B1 (en) 1987-05-12 1995-11-15 Serono Pharmazeutische Präparate GmbH Subcutaneous administration of human chorionic gonadotrophin
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US6018026A (en) 1988-01-22 2000-01-25 Zymogenetics, Inc. Biologically active dimerized and multimerized polypeptide fusions
AU4076589A (en) 1988-09-01 1990-04-02 Applied Research Systems Ars Holding N.V. Methods for producing gonadotropin and tsh super-agonists
GB8901778D0 (en) 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US6225449B1 (en) 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
EP0404458A3 (en) 1989-06-19 1992-03-04 Bunge (Australia) Proprietary Limited Ovine follicle stimulating hormone
DE69131978T2 (de) 1990-05-08 2000-10-05 Univ New Jersey Med Glykoproteinhormon-analoga mit veränderten immunologischen merkmalen, veränderter wirksamkeit und/oder rezeptorspezifität
WO1992002244A1 (en) 1990-07-31 1992-02-20 The Liposome Company, Inc. Accumulation of amino acids and peptides into liposomes
US5612034A (en) 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
WO1993019202A2 (en) 1992-03-10 1993-09-30 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Exchangeable template reaction
US5604198A (en) 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
RU2213099C2 (ru) * 1994-08-12 2003-09-27 Вашингтон Юниверсити Одноцепочечный белок, модулятор гормонов лютеинизирующего, фолликулостимулирующего, тиреостимулирующего и хорионического гонадотропина (варианты), молекула нуклеиновой кислоты (варианты), вектор (варианты), линия трансформированных клеток сно (варианты), способ продуцирования одноцепочечного белка (варианты)
US6020473A (en) 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US7005505B1 (en) 1995-08-25 2006-02-28 Genentech, Inc. Variants of vascular endothelial cell growth factor
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
EP1947117B1 (en) 1996-05-08 2013-07-17 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Glycoprotein hormone superagonists
US6361992B1 (en) * 1996-05-08 2002-03-26 The United States Of America As Represented By The Department Of Health And Human Services Thyroid stimulating hormone superagonists
JP2001517075A (ja) 1996-08-23 2001-10-02 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ 組換え血管内皮細胞増殖因子d(vegf―d)
JP2002511732A (ja) 1996-10-11 2002-04-16 ザ・テキサス・エイ・アンド・エム・ユニヴァーシティ・システム トランスジェニック動物を発生させるための組成物および方法
US6750044B1 (en) 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
US6485942B1 (en) 1997-02-14 2002-11-26 Genentech, Inc. Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
US6080912A (en) 1997-03-20 2000-06-27 Wisconsin Alumni Research Foundation Methods for creating transgenic animals
JP3950484B2 (ja) * 1997-06-25 2007-08-01 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ ジスルフィド架橋結合した糖タンパク質ホルモン類似体類およびそれらの調製および使用
US6281408B1 (en) 1998-02-20 2001-08-28 Thomas Jefferson University Efficient method for production of compound transgenic animals
CA2344277A1 (en) 1998-09-22 2000-03-30 University Of Maryland, Baltimore Cystine knot growth factor mutants
DE69931178T8 (de) 1998-11-02 2007-06-28 Ludwig Institute For Cancer Research Ein dem vaskularen endothelen wachstumsfaktor verwandtes protein aus orf virus nz10 bindet und aktiviert den säuger vegf rezeptor-2
US7112341B1 (en) * 1999-04-13 2006-09-26 Nektar Therapeutics Pulmonary administration of dry powder formulations for treating infertility
CA2373822A1 (en) 1999-05-20 2000-11-30 Scios Inc. Vascular endothelial growth factor variants
US6555660B2 (en) 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
US20020127652A1 (en) 2000-02-11 2002-09-12 Schambye Hans Thalsgard Follicle stimulating hormones
JP4689956B2 (ja) 2001-08-01 2011-06-01 ユニバーシティ オブ ブリストル 増殖因子イソ型
US20070184023A1 (en) 2003-10-30 2007-08-09 Pharmexa A/S Method for down-regulation of vegf
AU2004287645A1 (en) * 2003-11-06 2005-05-19 Compugen Ltd. Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
US8067368B2 (en) 2004-01-27 2011-11-29 The Ohio State University Research Foundation Vascular endothelial growth factors and methods of their use
AU2005223651B2 (en) * 2004-03-19 2012-07-12 Trophogen, Inc. Follicle stimulating hormone superagonists
BRPI0509469A (pt) 2004-03-31 2007-09-11 Trophogen Inc superagonistas do hormÈnio glicoprotéico humano e uso dos mesmos
CN101067118A (zh) * 2007-04-24 2007-11-07 新疆农业科学院微生物应用研究所 一种重组牛促卵泡激素在毕赤酵母中的表达
WO2011075606A2 (en) * 2009-12-18 2011-06-23 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
AU2013296709B2 (en) 2012-07-30 2018-03-08 Trophogen Inc. Glycoprotein hormone long-acting superagonists
US9905908B2 (en) 2014-01-14 2018-02-27 Luxshare Precision Industry Co., Ltd. Antenna structure with proximity sensor

Also Published As

Publication number Publication date
EP4012033A1 (en) 2022-06-15
US10766941B2 (en) 2020-09-08
US9187545B2 (en) 2015-11-17
CN112409472A (zh) 2021-02-26
CN104619846A (zh) 2015-05-13
EP3533874A1 (en) 2019-09-04
CN112458096A (zh) 2021-03-09
HRP20190847T1 (hr) 2019-09-06
CA3108181A1 (en) 2014-02-06
HUE044016T2 (hu) 2019-09-30
EP3572515B1 (en) 2021-07-21
RU2018132561A (ru) 2018-11-02
AU2013296709B2 (en) 2018-03-08
ES2894135T3 (es) 2022-02-11
ZA201502778B (en) 2021-09-29
JP2015524819A (ja) 2015-08-27
BR112015001885B1 (pt) 2022-08-09
ES2727659T3 (es) 2019-10-17
BR112015001885A2 (pt) 2017-11-07
EP2880164B1 (en) 2019-04-24
EP2880164A2 (en) 2015-06-10
DK2880164T3 (da) 2019-05-20
NZ707016A (en) 2017-08-25
RS58881B1 (sr) 2019-08-30
AU2018203815B2 (en) 2019-12-12
WO2014022283A3 (en) 2014-04-03
WO2014022283A2 (en) 2014-02-06
US20140031530A1 (en) 2014-01-30
CA2880520A1 (en) 2014-02-06
MX2015001414A (es) 2015-09-23
AR091936A1 (es) 2015-03-11
PT3572515T (pt) 2021-10-22
PT2880164T (pt) 2019-06-05
CA2880520C (en) 2021-02-09
JP6429774B2 (ja) 2018-11-28
EP3572515A1 (en) 2019-11-27
PL2880164T3 (pl) 2019-10-31
RU2015103059A (ru) 2016-09-27
RU2668174C2 (ru) 2018-09-26
EP2880164A4 (en) 2016-03-09
AU2013296709A1 (en) 2015-02-19
CN104619846B (zh) 2020-11-03
MX360717B (es) 2018-11-13
UA118653C2 (uk) 2019-02-25
US20140371146A1 (en) 2014-12-18
AU2018203815A1 (en) 2018-06-21
US20210054041A1 (en) 2021-02-25
US9249205B2 (en) 2016-02-02
US20160075751A1 (en) 2016-03-17
PL3572515T3 (pl) 2022-04-11
US20230357345A1 (en) 2023-11-09

Similar Documents

Publication Publication Date Title
CL2015003031A1 (es) Compuesto peptídico
DK2970441T3 (da) AGLYCOSYLEREDE Fc-INDEHOLDENDE POLYPEPTIDER
DK3587448T3 (da) Heterodimere proteiner
CL2015002750A1 (es) Anticuerpos humanos pac1
DK3041857T3 (da) Protein a-kromatografi
DK2996488T3 (da) Talloliefedtsyre
CL2014002180A1 (es) Peptidos antomicrobianos
FR2993464B1 (fr) Pansement interface autoporte
PT3061771T (pt) Novo péptido unido a quatro epitopos ctl
DK2861241T3 (da) Forbedrede cd31-peptider
HK1211596A1 (en) Peptide
DK3572515T3 (da) Glykoproteinhormon langtidsvirkende superagonister
DK3004134T3 (da) Peptid-ligering
HK1211595A1 (en) Peptide
HK1198769A1 (en) Novel peptide
DK2983690T3 (da) Neuropeptid Y-afledte peptider
GB201304973D0 (en) Recombinant protein
CU24181B1 (es) POLIPÉPTIDOS DERIVADOS DEL TGFß
FR3014440B1 (fr) Polypeptides entomotoxiques
DK2993246T3 (da) Flad stålwire
CL2014000649S1 (es) Sombrilla
ES1097881Y (es) Delantal con sujeción de fácil colocación
TH144599B (th) ร่ม
TH1401005679A (th) จุลินทรีย์รีคอมบิแนนท์
FI10392U1 (fi) Rataelementti